219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797632478371905536 |
|---|---|
| author | Laura Benjamin Mark Uhlik Frederick L Baehner Jessica Aldrich Luka Ausec Gargi D Basu Janine LoBello Snehal G Thakkar Matthew Halbert Patrick Eimerman Cynthia A Flannery Nishitha Therala David W Hall Daniel Pointing Lea Vohar Roman Lustrik Seema Iyer |
| author_facet | Laura Benjamin Mark Uhlik Frederick L Baehner Jessica Aldrich Luka Ausec Gargi D Basu Janine LoBello Snehal G Thakkar Matthew Halbert Patrick Eimerman Cynthia A Flannery Nishitha Therala David W Hall Daniel Pointing Lea Vohar Roman Lustrik Seema Iyer |
| author_sort | Laura Benjamin |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:38:38Z |
| format | Article |
| id | doaj.art-7457c363e7264209934d662481b7fc48 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:38:38Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-7457c363e7264209934d662481b7fc482023-11-10T11:10:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0219219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patientsLaura Benjamin0Mark Uhlik1Frederick L Baehner2Jessica Aldrich3Luka Ausec4Gargi D Basu5Janine LoBello6Snehal G Thakkar7Matthew Halbert8Patrick Eimerman9Cynthia A Flannery10Nishitha Therala11David W Hall12Daniel Pointing13Lea Vohar14Roman Lustrik15Seema Iyer16UCL Laboratory of Molecular and Cell Biology, London, UK1Biothera Pharmaceuticals, Eagan, MN, USADepartments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USATranslational Genomics Research Institute;5Genialis Inc., Boston, MA, USA1Exact Sciences, Phoenix, AZ, USA1Exact Sciences, Phoenix, AZ, USA1Exact Sciences, Phoenix, AZ, USA2Exact Sciences, Madison, WI, USA2Exact Sciences, Madison, WI, USA3Exact Sciences, Redwood City, CA, USA3Exact Sciences, Redwood City, CA, USA1Exact Sciences, Phoenix, AZ, USA5Genialis Inc., Boston, MA, USA5Genialis Inc., Boston, MA, USA5Genialis Inc., Boston, MA, USA7OncXerna Therapeutics, Bloomfield, NJ, USA |
| spellingShingle | Laura Benjamin Mark Uhlik Frederick L Baehner Jessica Aldrich Luka Ausec Gargi D Basu Janine LoBello Snehal G Thakkar Matthew Halbert Patrick Eimerman Cynthia A Flannery Nishitha Therala David W Hall Daniel Pointing Lea Vohar Roman Lustrik Seema Iyer 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients Journal for ImmunoTherapy of Cancer |
| title | 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients |
| title_full | 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients |
| title_fullStr | 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients |
| title_full_unstemmed | 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients |
| title_short | 219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients |
| title_sort | 219 prevalence of genomic alterations in xernatm tumor microenvironment subtypes in colorectal cancer patients |
| work_keys_str_mv | AT laurabenjamin 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT markuhlik 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT fredericklbaehner 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT jessicaaldrich 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT lukaausec 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT gargidbasu 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT janinelobello 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT snehalgthakkar 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT matthewhalbert 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT patrickeimerman 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT cynthiaaflannery 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT nishithatherala 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT davidwhall 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT danielpointing 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT leavohar 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT romanlustrik 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients AT seemaiyer 219prevalenceofgenomicalterationsinxernatmtumormicroenvironmentsubtypesincolorectalcancerpatients |